Lobato M F, Careche M, Ros M, Moreno F J, García-Ruíz J P
Mol Cell Biochem. 1985 May;67(1):19-23. doi: 10.1007/BF00220981.
The administration of 2 bromo-alpha-ergocryptine, to reduce serum prolactin decreased the activity of cytosolic P-enolpyruvate carboxykinase (GTP) (EC 4.1.1.32) about 50% in both liver and mammary gland of lactating animals. Adrenalectomy had similar effects to those of bromo-alpha-ergocryptine. In contrast, there was a 50% increase in enzyme activity in the mammary gland of diabetic, lactating rats and a 10-fold increase in liver as compared with normal rats. P-enolpyruvate carboxykinase activity in mammary gland as liver is coordinately regulated by prolactin, glucocorticoids and insulin.
给予2-溴-α-麦角隐亭以降低血清催乳素水平,可使泌乳动物肝脏和乳腺中胞质磷酸烯醇式丙酮酸羧激酶(GTP)(EC 4.1.1.32)的活性降低约50%。肾上腺切除术产生的效果与溴-α-麦角隐亭相似。相比之下,糖尿病泌乳大鼠乳腺中的酶活性比正常大鼠增加了50%,肝脏中的酶活性增加了10倍。乳腺和肝脏中的磷酸烯醇式丙酮酸羧激酶活性受催乳素、糖皮质激素和胰岛素的协同调节。